HubSpot Stock Soars 7% on Earnings Beat and Strong FY Guidanceby Mark Eisenberg 08.08.2024HubSpot shares surged 7% after robust Q2 earnings, beating estimates, and raising its full-year guidance, reaffirming growth momentum.
CVS Health Updates EPS Guidance and Operational Plansby Mark Eisenberg 08.08.2024CVS Health revises full-year EPS guidance to $6.40-$6.55 and plans significant operational improvements to drive future growth.
SoundThinking Q2 2024: Strong Growth with ShotSpotter Expansionby Mark Eisenberg 07.08.2024SoundThinking reports a robust 22% revenue increase in Q2 2024, driven by ShotSpotter expansion and strategic partnerships.
Power Integrations Reports Robust Q2 Earnings with 16% Revenue Growthby Mark Eisenberg 07.08.2024Power Integrations sees a 16% Q2 revenue boost, driven by a 70% surge in consumer sales. GaN technology acquisition strengthens ...
Comscore Reports Q2 2024 Earnings Reflecting Strategic Transitionby Mark Eisenberg 07.08.2024Comscore's Q2 2024 earnings show a decline in revenue but highlight a strategic shift towards growth by Q4 2024.
Supernus Pharmaceuticals Reports Strong Q2 2024 Growthby Mark Eisenberg 07.08.2024Supernus Pharmaceuticals sees a 24% YoY revenue increase in Q2 2024, driven by key drugs Qelbree and GOCOVRI.
Roundcube Flaws Expose Emails and Passwords to Hackersby Lilu Anderson 07.08.2024Hackers can exploit Roundcube flaws to steal emails, contacts, and passwords. Update to versions 1.6.8 or 1.5.8.
Expert Talks Cybersecurity After NWACC Ransomware Attackby Lilu Anderson 07.08.2024NWACC faces a ransomware attack just before fall semester. Experts weigh in on the impact and necessary cybersecurity measures.
McLaren Health Care Faces IT and Telephone Systems Disruptionby Lilu Anderson 07.08.2024McLaren Health Care is experiencing IT and phone system outages, impacting patient services. The health system is working to resolve ...
TG Therapeutics Raises 2024 Revenue Guidance Amid Soaring BRIUMVI Salesby Mark Eisenberg 07.08.2024TG Therapeutics' Q2 2024 results show BRIUMVI sales at $72.6M, prompting a revenue guidance raise to $290-$300M.